[go: up one dir, main page]

GR3036218T3 - Htlv-i/htlv-ii assay and method. - Google Patents

Htlv-i/htlv-ii assay and method.

Info

Publication number
GR3036218T3
GR3036218T3 GR20010401069T GR20010401069T GR3036218T3 GR 3036218 T3 GR3036218 T3 GR 3036218T3 GR 20010401069 T GR20010401069 T GR 20010401069T GR 20010401069 T GR20010401069 T GR 20010401069T GR 3036218 T3 GR3036218 T3 GR 3036218T3
Authority
GR
Greece
Prior art keywords
htlv
kit
peptide antigens
hltv
infection
Prior art date
Application number
GR20010401069T
Other languages
English (en)
Inventor
Steven K H Foung
Kenneth G Hadlock
Theresa P Chow
Original Assignee
Genelabs Tech Inc
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genelabs Tech Inc, Univ Leland Stanford Junior filed Critical Genelabs Tech Inc
Publication of GR3036218T3 publication Critical patent/GR3036218T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GR20010401069T 1992-02-24 2001-07-13 Htlv-i/htlv-ii assay and method. GR3036218T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84090692A 1992-02-24 1992-02-24
PCT/US1993/001498 WO1993017341A1 (en) 1992-02-24 1993-02-19 Htlv-i/htlv-ii assay and method

Publications (1)

Publication Number Publication Date
GR3036218T3 true GR3036218T3 (en) 2001-10-31

Family

ID=25283539

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010401069T GR3036218T3 (en) 1992-02-24 2001-07-13 Htlv-i/htlv-ii assay and method.

Country Status (11)

Country Link
US (1) US6110662A (el)
EP (1) EP0643835B1 (el)
JP (1) JP3506252B2 (el)
AT (1) ATE200709T1 (el)
CA (1) CA2117378C (el)
DE (1) DE69330164T2 (el)
ES (1) ES2159291T3 (el)
GR (1) GR3036218T3 (el)
HK (1) HK1013328A1 (el)
PT (1) PT643835E (el)
WO (1) WO1993017341A1 (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773211A (en) * 1991-07-10 1998-06-30 Abbott Laboratories Differentiation of HTLV-I and HTLV-II using synthetic peptides
JPH09500013A (ja) * 1993-06-01 1997-01-07 ライフ・テクノロジーズ・インコーポレイテッド カチオン性脂質による遺伝子免疫
WO1995017678A2 (en) * 1993-12-20 1995-06-29 Abbott Laboratories Differentiation of htlv-i and htlv-ii using synthetic peptides
US6989434B1 (en) 1994-02-11 2006-01-24 Invitrogen Corporation Reagents for intracellular delivery of macromolecules
JPH10507921A (ja) 1994-10-28 1998-08-04 イノジェネティックス・ナムローゼ・フェンノートシャップ 原核生物の検出および識別のためのポリ核酸配列
US5795587A (en) 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
US20030069173A1 (en) * 1998-03-16 2003-04-10 Life Technologies, Inc. Peptide-enhanced transfections
JP4854853B2 (ja) 1998-11-12 2012-01-18 ライフ テクノロジーズ コーポレーション トランスフェクション薬剤
US8158405B2 (en) * 2008-06-30 2012-04-17 General Electric Company Process for concentrating and processing fluid samples
EP3067697B1 (en) 2013-11-06 2019-05-08 Fujirebio Inc. Method for reducing non-specific reactions in immunoassay of anti-htlv antibodies
EP2913338A1 (en) * 2014-02-28 2015-09-02 Roche Diagniostics GmbH Soluable and immunoreactive variants of HTLV capsid antigen p24
WO2016011203A1 (en) 2014-07-15 2016-01-21 Life Technologies Corporation Compositions with lipid aggregates and methods for efficient delivery of molecules to cells

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU600224B2 (en) * 1984-09-19 1990-08-09 Regents Of The University Of California, The Retroviral polypeptides associated with human cellular transformation
GB8607101D0 (en) * 1986-03-21 1986-04-30 Serono Diagnostics Ltd Immunoassay
JPS62296889A (ja) * 1986-05-14 1987-12-24 Fujirebio Inc Ｈｔｌｖ−ｉ抗原活性を有する蛋白及びその製造法
JP2501569B2 (ja) * 1986-11-14 1996-05-29 協和醗酵工業株式会社 抗成人ｔ細胞白血病ウイルス抗体の検出法
US5066579A (en) 1986-12-31 1991-11-19 Genelabs Incorporated HTLV-I peptide antigen and assay
US5614366A (en) * 1986-12-31 1997-03-25 Genelabs Technologies, Inc. HTLV-I peptide antigens and kit
US5039604A (en) * 1987-08-21 1991-08-13 Cellular Products, Inc. Test device and method of preparing same, assay kit and method for the simultaneous detection of two HTLV or HIV antibodies
US5017687A (en) * 1988-03-10 1991-05-21 Virovahl, S.A. Peptides for the detection of HTLV-1 infection
US5003043A (en) * 1988-05-25 1991-03-26 Triton Biosciences Inc. Peptides representing epitopic sites for the major HTLV-I envelope protein, antibodies thereto, and uses thereof
DE69015708T2 (de) * 1989-01-13 1995-06-08 United Biomedical Inc., Lake Success, N.Y. Künstliche peptid-zusammensetzungen mit immunoreaktiven antikörpern von htlv-1.
SE8900721D0 (sv) * 1989-03-02 1989-03-02 Blomberg Jonas Methods for detection of antibodies to
SE467542B (sv) * 1989-06-13 1992-08-03 Syntello Ab Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar
JP2525054B2 (ja) * 1989-08-01 1996-08-14 株式会社トクヤマ 成人ｔ細胞白血病ウィルス感染診断薬
US5283320A (en) * 1989-11-13 1994-02-01 Syntello Ab Peptides for HTLV-2 infection diagnosis of, therapy for, vaccination against, for distinguishing between HTLV-1 and HTLV-2 infections and antibodies derived therefrom
FI910245L (fi) * 1990-01-24 1991-07-25 United Biomedical Inc Syntetiska peptidkompositioner med immunoreaktivitet mot htlv-antikroppar.
US5359029A (en) * 1990-07-18 1994-10-25 Biochem Immunosystems Inc. Peptides and analogues and mixtures thereof for detecting antibodies to HTLV-I and HTLV-II viruses
NZ238855A (en) * 1990-07-18 1994-03-25 Iaf Biochem Int Peptides, mixtures thereof and compositions useful for detecting htlv-i and htlv-ii infections
WO1992004046A1 (en) * 1990-08-29 1992-03-19 The United States Of America, Represented By The Secretary, United States Department Of Commerce Novel peptide antigens and immunoassays, test kits and vaccines using the same
JPH04164097A (ja) * 1990-10-24 1992-06-09 Kuraray Co Ltd ペプチドおよびその用途
ATE180495T1 (de) * 1991-07-10 1999-06-15 Abbott Lab Unterscheidung von htlv-i und htlv-ii unter verwendung von synthetischen peptiden
AU2412692A (en) * 1991-07-23 1993-02-23 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Novel peptide antigens and immunoassays, test kits and vaccines using the same
JPH07502493A (ja) * 1991-10-08 1995-03-16 デューク・ユニバーシテイ Ｈｔｌｖの抗原決定基に対応するペプチド
AU660752B2 (en) * 1991-11-25 1995-07-06 Dade International Inc. Immunoassay using synthetic HTLV-11 peptides

Also Published As

Publication number Publication date
EP0643835B1 (en) 2001-04-18
JPH07504036A (ja) 1995-04-27
DE69330164D1 (de) 2001-05-23
EP0643835A1 (en) 1995-03-22
ATE200709T1 (de) 2001-05-15
US6110662A (en) 2000-08-29
PT643835E (pt) 2001-10-30
ES2159291T3 (es) 2001-10-01
HK1013328A1 (en) 1999-08-20
EP0643835A4 (en) 1996-04-03
DE69330164T2 (de) 2002-01-17
CA2117378A1 (en) 1993-09-02
JP3506252B2 (ja) 2004-03-15
WO1993017341A1 (en) 1993-09-02
CA2117378C (en) 2003-04-15

Similar Documents

Publication Publication Date Title
ATE282828T1 (de) Schnelltest zur gleichzeitigen spezifischen bestimmung von hiv-antikörpern
ATE223575T1 (de) Einstufige immunochromatographische vorrichtung und verfahren zu ihrer verwendung
ATE80735T1 (de) Kolorimetrisches immunoessay auf fester oberflaeche, sowie dazu zu verwendender teststab und seine herstellung.
ATE98700T1 (de) Anti-fr-900506-stoffe-antikoerper und hoechstempfindliches enzym-immunoassay-verfahren.
HK1013328A1 (en) Htlv-i/htlv-ii assay and method
JPH11511851A (ja) 細胞計数イムノアッセイ
ATE190728T1 (de) Verfahren zur quantitativen bestimmung menschlichen akutphasen-serum-amyloid-a-proteins; rekombinantes protein; spezifischer antikörper
RU2213973C2 (ru) СПОСОБ ОПРЕДЕЛЕНИЯ АНТИБИОТИКОВ, СОДЕРЖАЩИХ β-ЛАКТАМНЫЙ ЦИКЛ, В ЖИДКОСТИ БИОЛОГИЧЕСКОГО ПРОИСХОЖДЕНИЯ И АНАЛИТИЧЕСКИЙ НАБОР ДЛЯ ЕГО ОСУЩЕСТВЛЕНИЯ
CY1107621T1 (el) Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα
EP2048505A3 (de) Verfahren zur Früherkennung der Serokonversion eines gegen Hepatitis C-Virus gerichteten Antikörpers
ES8304314A1 (es) "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles".
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
EP0381450A3 (en) Assay for bone alkaline phosphatase
ES2141348T3 (es) Metodo de deteccion de la presencia de una especie de mycobacterium, kit y anticuerpos utilizados en este metodo.
NZ334809A (en) Assay for the detection of antibodies against p53
EP0387027A3 (en) Endometriosis diagnosis methods and reagents
AU2375695A (en) Solid-phase filtration method for antigen and antibody assays in bloodgroup serology, and test kit
MY106963A (en) Agglutination assay.
Levine et al. Fast ELISA for measuring serum antibody responses
EP0985931A3 (en) Recombinant antigen immunoassay for the diagnosis of syphilis
ATE24055T1 (de) Heterogenes testverfahren fuer antigenische biologische substanzen mittels antikoerperhybridkonjugaten und reagens dafuer.
CA2550264A1 (en) Method and device for detecting feline immunodeficiency virus
NO895007L (no) Simultan enzym-immunoanalyse for deteksjon av antigen og/eller antistoff i mennesker.
UA66095A (en) IMMUNOENZYME ASSAY KIT FOR DETECTING IgG AGAINST HERPES VIRUSES TYPES I AND II IN HUMAN BLOOD SERUM (DIA-HSV 1/2-IgG)